The biotechnology company, which focuses on multiple sclerosis treatments, was chosen as Monday's IBD 50 Growth Stocks To Watch selection. Wall Street anticipates explosive earnings growth for TG Therapeutics in the upcoming quarters, contributing to its strong performance as it recovers from a sharp drop earlier this month.